Kenya Nishioka Motoki Fujimaki Kazuaki Kanai Yuta Ishiguro Tomoko Nakazato Ryota Tanaka Kazumasa Yokoyama Nobutaka Hattori
10.2169/internalmedicine.56.7578
Intern Med
2017;56(1):101-104.
CC BY-NC-ND
https://pubmed.ncbi.nlm.nih.gov/28049985/
Antineoplastic Agents / therapeutic use Carcinoma, Renal Cell / complications Carcinoma, Renal Cell / drug therapy Immunoglobulins, Intravenous / therapeutic use Polyradiculoneuropathy, Chronic Inflammatory Demyelinating / chemically induced Polyradiculoneuropathy, Chronic Inflammatory Demyelinating / drug therapy
Antineoplastic Agents / therapeutic use Carcinoma, Renal Cell / complications Carcinoma, Renal Cell / drug therapy Immunoglobulins, Intravenous / therapeutic use Polyradiculoneuropathy, Chronic Inflammatory Demyelinating / chemically induced Polyradiculoneuropathy, Chronic Inflammatory Demyelinating / drug therapy Case Reports Humans Male Middle Aged Polyradiculoneuropathy, Chronic Inflammatory Demyelinating / diagnosis Treatment Outcome Antineoplastic Agents Immunoglobulins, Intravenous
PMC5313433
28049985
Demyelinating Peripheral Neuropathy Due to Renal Cell Carcinoma
2017